Literature DB >> 20929967

On identifying magnocellular and parvocellular responses on the basis of contrast-response functions.

Bernt C Skottun1, John R Skoyles.   

Abstract

It has been proposed that magnocellular and parvocellular sensitivity in schizophrenic individuals can be assessed using steady-state visually evoked potentials (VEPs) to either low-contrast stimuli or stimuli whose contrast is modulated around a high contrast "pedestal" (Green MF, Butler PD, Chen Y, et al. Schizophr Bull. 2009;35:163-181). This suggestion faces 2 difficulties: (1) To use low-contrast stimuli to activate the magnocellular system is inconsistent with lesion studies that have shown that under many conditions, the parvocellular system responds to the lowest contrasts and (2) To rely on contrast-response relationships to identify magnocellular and parvocellular responses is difficult because other neurons exist in the visual system that have contrast-response relationships similar to those of magnocellular and parvocellular cells.

Entities:  

Mesh:

Year:  2010        PMID: 20929967      PMCID: PMC3004196          DOI: 10.1093/schbul/sbq114

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  38 in total

1.  Reaction times in the detection of gratings by human observers: a probabilistic mechanism.

Authors:  D J Tolhurst
Journal:  Vision Res       Date:  1975-10       Impact factor: 1.886

2.  Bypassing V1: a direct geniculate input to area MT.

Authors:  Lawrence C Sincich; Ken F Park; Melville J Wohlgemuth; Jonathan C Horton
Journal:  Nat Neurosci       Date:  2004-09-19       Impact factor: 24.884

3.  The effects of parvocellular lateral geniculate lesions on the acuity and contrast sensitivity of macaque monkeys.

Authors:  W H Merigan; L M Katz; J H Maunsell
Journal:  J Neurosci       Date:  1991-04       Impact factor: 6.167

4.  The parvocellular LGN provides a robust disynaptic input to the visual motion area MT.

Authors:  Jonathan J Nassi; David C Lyon; Edward M Callaway
Journal:  Neuron       Date:  2006-04-20       Impact factor: 17.173

5.  Adaptable mechanisms that regulate the contrast response of neurons in the primate lateral geniculate nucleus.

Authors:  Aaron J Camp; Chris Tailby; Samuel G Solomon
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

6.  Coding of image contrast in central visual pathways of the macaque monkey.

Authors:  G Sclar; J H Maunsell; P Lennie
Journal:  Vision Res       Date:  1990       Impact factor: 1.886

Review 7.  Psychophysical evidence for separate channels for the perception of form, color, movement, and depth.

Authors:  M S Livingstone; D H Hubel
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

Review 8.  Contrast sensitivity and magnocellular functioning in schizophrenia.

Authors:  Bernt C Skottun; John R Skoyles
Journal:  Vision Res       Date:  2007-09-06       Impact factor: 1.886

9.  Sensory contributions to impaired emotion processing in schizophrenia.

Authors:  Pamela D Butler; Ilana Y Abeles; Nicole G Weiskopf; Arielle Tambini; Maria Jalbrzikowski; Michael E Legatt; Vance Zemon; James Loughead; Ruben C Gur; Daniel C Javitt
Journal:  Schizophr Bull       Date:  2009-09-30       Impact factor: 9.306

Review 10.  Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.

Authors:  Michael F Green; Pamela D Butler; Yue Chen; Mark A Geyer; Steven Silverstein; Jonathan K Wynn; Jong H Yoon; Vance Zemon
Journal:  Schizophr Bull       Date:  2008-11-20       Impact factor: 9.306

View more
  11 in total

1.  Enhanced brain responses to color during smooth-pursuit eye movements.

Authors:  Jing Chen; Matteo Valsecchi; Karl R Gegenfurtner
Journal:  J Neurophysiol       Date:  2017-05-03       Impact factor: 2.714

Review 2.  Ophthalmology issues in schizophrenia.

Authors:  Carolina P B Gracitelli; Ricardo Y Abe; Alberto Diniz-Filho; Fabiana Benites Vaz-de-Lima; Augusto Paranhos; Felipe A Medeiros
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

3.  New visual information processing abnormality biomarker for the diagnosis of Schizophrenia.

Authors:  Ivan Koychev; Wael El-Deredy; John Francis William Deakin
Journal:  Expert Opin Med Diagn       Date:  2011-07-01

4.  Visual field loss in schizophrenia: evaluation of magnocellular pathway dysfunction in schizophrenic patients and their parents.

Authors:  Carolina Pelegrini Barbosa Gracitelli; Fabiana Benites Vaz de Lima; Rodrigo A Bressan; Augusto Paranhos Junior
Journal:  Clin Ophthalmol       Date:  2013-05-29

5.  Omega-3 fatty acids modify human cortical visual processing--a double-blind, crossover study.

Authors:  Isabelle Bauer; David P Crewther; Andrew Pipingas; Renee Rowsell; Robyn Cockerell; Sheila G Crewther
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

Review 6.  Dyslexia: the Role of Vision and Visual Attention.

Authors:  John Stein
Journal:  Curr Dev Disord Rep       Date:  2014

Review 7.  What is Developmental Dyslexia?

Authors:  John Stein
Journal:  Brain Sci       Date:  2018-02-04

8.  Objective Assessment of the Effect of Optical Treatment on Magnocellular and Parvocellular-biased Visual Response in Anisometropic Amblyopia.

Authors:  Zitian Liu; Zidong Chen; Yunzhi Xu; Lei Feng; Junpeng Yuan; Daming Deng; Ying Han; Minbin Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

9.  Neuropsychological functions and visual contrast sensitivity in schizophrenia: the potential impact of comorbid posttraumatic stress disorder (PTSD).

Authors:  Ibolya Halász; Einat Levy-Gigi; Oguz Kelemen; György Benedek; Szabolcs Kéri
Journal:  Front Psychol       Date:  2013-03-20

10.  Reduced crowding and poor contour detection in schizophrenia are consistent with weak surround inhibition.

Authors:  Valentina Robol; Marc S Tibber; Elaine J Anderson; Tracy Bobin; Patricia Carlin; Sukhwinder S Shergill; Steven C Dakin
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.